Concourse Financial Group Securities’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Hold |
0
| – | – | – | 10398 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 10159 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 9924 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 9676 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 9456 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 9098 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 9107 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 8914 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 8745 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8545 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 8252 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7818 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7454 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7134 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 6848 |
|